Third Rock Ventures II L.P. 13D/13G Filings for Allena Pharmaceuticals, Inc. (ALNAQ)

Third Rock Ventures II L.P. 13D and 13G filings for Allena Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-14
4:09 pm
Sale
2022-12-3113GAllena Pharmaceuticals, Inc.
ALNAQ
Third Rock Ventures II L.P.0
0.000%
-2,790,964decrease
(Position Closed)
Filing